Lantiseptic recalled over manufacturing violations

Recall date

August 27, 2025

Source

U.S. Food & Drug Administration (FDA) — enforcement report

Official notice title

DermaRite Industries, LLC recalls Lantiseptic, Dry Skin Therapy, Lanolin USP 30%, packaged in a) 5 g (0.17 oz) (NDC 61924-504-05), b) 4 oz (NDC 61924-504…

Recall number

D-0169-2026

FDA classification

Class II

Brand / firm

DermaRite Industries, LLC

Sold / distributed

Nationwide in the USA

Why it was recalled

CGMP Deviation; manufactured at the same facility where other products and lots were found to be contaminated.

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Lantiseptic, Dry Skin Therapy, Lanolin USP 30%, packaged in a) 5 g (0.17 oz) (NDC 61924-504-05), b) 4 oz (NDC 61924-504-04), and c)14 oz (NDC 61924-710-14) tubes, DermaRite Industries LLC, 7777 West Side Avenue, North Bergen, NJ 07047.